What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-04-03 compared with 2025-04-01 · 53 added, 22 removed, 5 unchanged (94% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER

MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

this section, we provide information about the market for our common equity, the number of holders of our common stock, our dividend

practices, and our repurchases of equity securities.

In addition, we provide disclosures regarding our equity compensation plans and

our policies and practices for granting stock options and stock appreciation rights, including awards made in close proximity to the

release of material nonpublic information, as required under recently adopted SEC rules.

common stock is listed on the Nasdaq Capital Market under the symbol “SBFM”.

As of April 1, 2025, we had a total of

2,707,541 shares of our common stock issued and outstanding.

We also have tradeable warrants exercisable to purchase shares of our

common stock listed on the Nasdaq Capital Market under the symbol “SBFMW.” As of April 1, 2025, we had 482 tradeable

warrants outstanding exercisable at $220.00 per warrant.

of April 1, 2025, there were approximately 149 holders of record of our common stock, not including those holding their shares in

“street name.”

Compensation Plan Information

following table sets forth information regarding our equity compensation plans as of December 31, 2024:

of Securities to be Issued Upon Exercise of Outstanding Options,

Warrants and Rights

Weighted-Average

Exercise Price of Outstanding Options, Warrants and Rights

of Securities

Remaining Available for

Issuance Under

Equity Compensation Plans

compensation plans approved by security holders*

compensation plans not approved by security holders

our 2023 Equity Incentive Plan.

As of April 2, 2026, we had 4,905,945 shares

of our common stock issued and outstanding.

We also have tradeable warrants exercisable to purchase shares of our common stock listed

on the Nasdaq Capital Market under the symbol “SBFMW.” As of April 2, 2026, we had 482 tradeable warrants outstanding exercisable

at $220.00 per warrant.

of April 2, 2026, there were approximately 117 holders of record of our common stock.

The total number of beneficial owners exceeds holders

of record due to Street-Name holdings.

have not paid any dividends since our incorporation and do not anticipate paying any dividends in the foreseeable future.

2 unchanged sentences

among other factors, our earnings, capital requirements, and operating financial conditions.

Sales of Unregistered Securities

Repurchases of Equity Securities

did not repurchase any shares of our common stock during the three months ended December 31, 2025.

We currently do not have a Rule 10b5-1

plan or other repurchase arrangements in place.

Equity Compensation Plan Information

The following table sets forth information regarding

our equity compensation plans as of December 31, 2025:

Plan Category

Number of Securities

Upon Exercise

of Outstanding

Options, Warrants

Weighted-Average

Exercise Price of

Outstanding Options,

Warrants and Rights

Number of Securities

Remaining Available for

Future Issuance Under

Equity Compensation Plans

Equity compensation plans approved by security holders*

Equity compensation plans not approved by security holders

*Represents our 2023 Equity Incentive Plan as amended

on December 11, 2025 at the Company’s 2025 Annual General Meeting of the shareholders.

and SAR Grant Timing in Relation to MNPI Releases

have established policies and practices governing the timing and administration of equity awards, including stock options and stock appreciation

rights (“SARs”).

We may grant equity awards pursuant to our 2023 Equity Incentive Plan, as approved by the Compensation Committee,

the Board of Directors at regularly scheduled meetings or by unanimous written consent.

We do not coordinate the timing of option or

SAR grants with the release of material non-public information (“MNPI”), nor do we time the public disclosure of MNPI for

the purpose of affecting the value of executive compensation.

We have not granted any such awards to date.

have not granted stock options or SARs to any executive officer in periods proximate to the release of MNPI, as defined in Item 402(x)

of Regulation S-K.

Accordingly, no tabular disclosure under Item 402(x)(2) is required for the fiscal years ended December 31, 2024 and

If we were to grant options or SARs in such circumstances in the future, we would provide the required tabular disclosure in accordance

with SEC rules.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity